Publication | Open Access
Clinicopathological characteristics and treatment outcomes of advanced <scp>SMARCA4‐deficient</scp> thoracic tumors
10
Citations
26
References
2023
Year
SMARCA4-deficient thoracic tumors exhibit distinct characteristics from conventional NSCLCs, and PD-1 inhibitors show promise in treating advanced SMARCA4-deficient thoracic tumors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1